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Cardiovascular disease is the leading cause
of death and hospitalization among adults.
An association between air pollution and
morbidity/mortality from cardiovascular dis-
ease has been recognized in epidemiologic and
clinical studies (Brook et al. 2004; Delfino
et al. 2005; Dominici et al. 2006; Pope et al.
2002; Sun et al. 2005), but the mechanisms
by which inhaled fibers or particles mediate
the exacerbation of atherosclerosis are unclear.
Moreover, elucidating the in vivo mechanisms
of action of the multiple gaseous and particu-
late components of air pollution is challenging
because of their physical and chemical com-
plexity and dynamic nature of reactivity.
Current theories purport that ﬁne (≤ 2.5 μm
in diameter) or ultraﬁne (≤ 0.1 μm in diame-
ter) particles or their metal components (e.g.,
iron, vanadium) preferentially induce cardio-
vascular disease via nonspeciﬁc inﬂammation
in lung, direct translocation to heart tissue,
and site-speciﬁc effects or altered autonomic
cardiac responses (Nel 2005; Oberdörster and
Utell 2002; Pope et al. 2002; Pope and
Dockery 2006).
The mechanisms of lung inflammation
and disease by asbestos have been widely
studied (Haegens et al. 2007; Janssen et al.
1997; Mossman et al. 2000) and its associa-
tion with cardiovascular disease reported in
occupational cohorts (Dement et al. 1983;
McDonald et al. 1993; Sanden et al. 1993;
Sjogren 1997, 2001). However, to our
knowledge, no studies examining the mecha-
nisms of the exacerbation of atherosclerosis
by inhaled asbestos have been performed.
Therefore, to test the hypothesis that airborne
ﬁbers exacerbate atherosclerosis and to eluci-
date the mechanisms involved, we used
chrysotile asbestos fibers in a murine model
of inhalation. Chrysotile asbestos is ubiqui-
tous in the northern hemisphere and is the
asbestos type historically used worldwide in
> 95% of asbestos-containing products
(Mossman et al. 1990). Although signiﬁcant
efforts have been made to reduce occupational
and environmental exposure to amphibole
types of asbestos (crocidolite, amosite) that
may be more pathogenic in mesothelioma
(Mossman and Gee 1989), the use of
chrysotile asbestos continues worldwide
(Nicholson 1997). Moreover, analysis of air-
borne surface dust in residential areas of Lower
Manhattan after the collapse of the World
Trade Center in New York City revealed
increased chrysotile asbestos [Centers for
Disease Control and Prevention (CDC) 2003],
raising the concern about its short- and long-
term pathogenic effects after inhalation by the
general population.
In these experiments, we used the athero-
sclerosis-prone apolipoprotein E–deficient
(ApoE–/–) mouse and ApoE–/– mice crossed
with CD4–/– [double-knockout (DKO)] mice
to test the hypothesis that inhaled asbestos
fibers exacerbate atherosclerosis and that the
mechanism involves CD4+ T cells that are
increased in lung after inhalation of asbestos
(Shukla et al. 2007). We exposed the mice to
ambient air, fine titanium dioxide (TiO2; a
nonpathogenic control particle), or chrysotile
asbestos in the University of Vermont (UVM)
Inhalation Facility (Sabo-Attwood et al. 2005).
Our data are the ﬁrst to show a direct relation-
ship between inhaled pathogenic ﬁbers and the
exacerbation of atherosclerosis via a CD4+
T cell–dependent process. Moreover, they sug-
gest an important role for activation of mono-
cyte chemoattractant protein-1 (MCP-1) and
early transcription factors activator protein-1
(AP-1) and nuclear factor-κB (NF-κB) in the
development of atherosclerosis by inhaled
pathogenic pollutants.
Materials and Methods
Animals. We maintained male and female
breeding C57BL/6, ApoE–/–, and CD4–/–
mice, purchased from Jackson Laboratories
(Bar Harbor, ME), by brother/sister mat-
ings at UVM. We used the B6.129S2-
Cd4tm1Mak strain of CD4–/– mice, the same
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BACKGROUND: Associations between air pollution and morbidity/mortality from cardiovascular
disease are recognized in epidemiologic and clinical studies, but the mechanisms by which inhaled
ﬁbers or particles mediate the exacerbation of atherosclerosis are unclear.
OBJECTIVE AND METHODS: To determine whether lung inflammation after inhalation of a well-
characterized pathogenic particulate, chrysotile asbestos, is directly linked to exacerbation of athero-
sclerosis and the mechanisms involved, we exposed apolipoprotein E–deﬁcient (ApoE–/–) mice and
ApoE–/– mice crossed with CD4–/– mice to ambient air, NIEHS (National Institute of
Environmental Health Sciences) reference sample of chrysotile asbestos, or ﬁne titanium dioxide
(TiO2), a nonpathogenic control particle, for 3, 9, or 30 days. 
RESULTS: ApoE–/– mice exposed to inhaled asbestos ﬁbers had approximately 3-fold larger athero-
sclerotic lesions than did TiO2-exposed ApoE–/– mice or asbestos-exposed ApoE–/–/CD4–/– double-
knockout (DKO) mice. Lung inflammation and the magnitude of lung fibrosis assessed
histologically were similar in asbestos-exposed ApoE–/– and DKO mice. Monocyte chemoattractant
protein-1 (MCP-1) levels were increased in bronchoalveolar lavage ﬂuid and plasma, and plasma
concentrations correlated with lesion size (p < 0.04) in asbestos-exposed ApoE–/– mice. At 9 days,
activator protein-1 (AP-1) and nuclear factor-κB (NF-κB), transcription factors linked to inﬂamma-
tion and found in the promoter region of the MCP-1 gene, were increased in aortas of asbestos-
exposed ApoE–/– but not DKO mice.
CONCLUSION: Our ﬁndings show that the degree of lung inﬂammation and ﬁbrosis does not corre-
late directly with cardiovascular effects of inhaled asbestos ﬁbers and support a critical role of CD4+
T cells in linking fiber-induced pulmonary signaling to consequent activation of AP-1– and
NF-κB–regulated genes in atherogenesis.
KEY WORDS: AP-1, atherosclerosis, CD4+ T-cells, chrysotile asbestos, ﬁbrosis, inﬂammation, knock-
out mice, lung, MCP-1, NF-κB. Environ Health Perspect 116:1218–1225 (2008). doi:10.1289/
ehp.11172 available via http://dx.doi.org/ [Online 21 May 2008]background as the ApoE–/– mice used in these
experiments. Female offspring were used in our
experiments. Double knockout (DKO) ani-
mals (ApoE–/– and CD4–/–) were generated by
producing F2 generation mice between
ApoE–/– and CD4–/– and using polymerase
chain reaction (PCR) to select mice that were
homozygous for both gene knockouts. We
then maintained homozygous ApoE–/–/CD4–/–
DKO mice by brother/sister matings. Animals
homozygous for both genes were used in the
experiments. The DKO mice were selected in
the F2 offspring by genotyping using PCR
protocols and were backcrossed into the
C57BL/6 background for more than eight
generations. We maintained both strains as
colonies at UVM and fed them normal chow.
All procedures were approved by the UVM
Institutional Committee on Use and Care of
Animals. We treated mice humanely and with
regard for the attenuation of suffering. We
weighed all animals after anesthesia and found
no differences between groups and treatments
(data not shown).
Inhalation procedures and sample collec-
tion. ApoE–/– or DKO mice at 4–6 weeks of
age were exposed to chrysotile asbestos
[Mg3Si2O5(OH)4; National Institute of
Environmental Health Sciences (NIEHS) 
reference sample at approximately 5 mg/m3
air; range, 4.7–5.7 mg/m3 air] for 6 hr/day,
5 days/week. This concentration is equivalent
historically to concentrations of chrysotile
asbestos in unregulated workplaces and levels
that caused lung diseases, and in air during the
World Trade Center disaster (CDC 2003).
The size dimensions (mean aerodynamic
diameter, 0.34 μm) of aerosolized NIEHS
chrysotile asbestos have been reported previ-
ously (BéruBé et al. 1996). 
We conducted whole-body inhalation
exposures within our inhalation facility
(accredited by the Association for Assessment
of Laboratory Animal Care) as described pre-
viously (Sabo-Attwood et al. 2005). We
exposed control animals (sham groups) to
clean, ambient air. We studied younger ani-
mals with early lesion development to opti-
mize the likelihood of detecting differences in
lesion size as a consequence of exposure. If we
had used older animals with larger lesions,
lengths of exposure to asbestos ﬁbers may not
have elicited easily detectable differences in
lesion size.
Because the schedule of exposure was
5 days/week, simulating a workplace setting,
30 days of exposure is equivalent to 6 weeks.
We used shorter exposures to determine
whether differences in early responses to
asbestos might reveal potential mechanisms
responsible for triggering differential lesion
sizes at the end of 30 days of exposure, a time
point previously shown to be associated with
lung ﬁbrogenesis (Sabo-Attwood et al. 2005). 
We used ﬁne TiO2 (0.2–2.5 μm diameter;
Fisher Scientific, Pittsburgh, PA) as a non-
pathogenic particle control at surface area con-
centrations approximately equal to those of
asbestos (~ 28 mg/m3 air) in some of the
experiments using ApoE–/– mice. After 3, 9, or
30 days of exposure, we collected bronchoalve-
olar lavage ﬂuid (BALF) and blood, aorta, and
lung tissues and prepared them for analyses.
We performed surgical procedures after inject-
ing the mice intraperitoneally with sodium
pentobarbital. We collected blood via cardiac
puncture into tubes with sodium EDTA as the
anticoagulant, and saved the plasma for
chemokine/cytokine assays. Tracheas of mice
were cannulated with polyethylene tubing, and
the lungs lavaged with sterile calcium- and
magnesium-free phosphate-buffered saline
(PBS) in a total volume of 1 mL. 
Mouse lung, heart, and aorta were dis-
sected and immersion ﬁxed overnight in 3%
paraformaldehyde/PBS at 4°C as previously
described (Taatjes et al. 2000; Wadsworth
et al. 2002). During ﬁxation, we bisected the
hearts with a cut parallel to both atria. The
hearts and lungs were immersed in optimal
cutting temperature compound (OCT;
Tissue-Tek, Torrance, CA) in labeled embed-
ding molds (hearts were oriented cut side up
so that the ﬁrst sections taken would reveal the
sinus area), snap-frozen in liquid-nitrogen–
cooled 2-methyl butane, and stored at –80°C
until the time of cryostat sectioning, as previ-
ously described (Paigen et al. 1987). 
We deﬁned the area for sectioning by three
prominent valve cusps at the juncture of the
aortic sinus region to the end of the valve
region, when the valves disappeared and the
aorta became more rounded in appearance.The
sections on the slides were air-dried for 30 min
to ensure proper adhesion before being stored
in a slide box at –80°C. En face preparations
were not done in these experiments because
the thoracic and abdominal aortas were used
for nuclear and cytoplasmic protein extraction
for analyses of transcription factors.
Aortic lesion quantitation. We examined
oil red O–stained sections (Pearse method)
using an Olympus BX50 upright light micro-
scope (Olympus America, Inc., Lake Success,
NY) with an attached Optronics MagnaFire
digital camera (Optical Analysis Corp.,
Nashua, NH). The sections were imaged with
a 4× objective lens, and we used MagnaFire
software (version 2.0) to capture 1,280 ×
1,024 pixel RGB digital images. We per-
formed computer-assisted image analysis
using MetaMorph software (Universal
Imaging Corp., Downingtown, PA) essen-
tially according to previously published proto-
cols (Wadsworth et al. 2002). We opened
cropped digital images and set the appropriate
(precalibrated) objective calibration by choos-
ing “Measure/Calibrate Distance/Apply.”
This allowed area measurements to be
expressed in calibrated square micrometer val-
ues; pixel values were displayed at the bottom
of the screen. The images were then assigned
threshold values for pixel measurements. Once
this was done, the “Integrated Morphometry”
feature measured the thresholded area and
logged the area values onto a Microsoft Excel
spreadsheet (Microsoft Corp., Redmond,
WA). The logged values were then converted
into an Excel chart for presentation. Animal
comparisons were calculated and expressed as
area values.
Fiber deposition studies in lung and
aorta. To compare the fiber burden in lung
with that in aorta, we digested the left lobes
and aortas of two control and two asbestos-
exposed mice in hypochlorite, a process that
does not affect fiber integrity, as previously
described (BéruBé et al. 1996). We transferred
the digest to Nuclepore ﬁlters and examined
them by scanning electron microscopy and
X-ray energy-dispersive spectroscopy at 5,000×
magniﬁcation. We evaluated 10 random ﬁelds
per ﬁlter.
Cholesterol measurement. We measured
total cholesterol in mouse plasma in the early
experiments using a standard commercial
cholesterol esterase enzymatic assay (Cayman
Chemical Co., Ann Arbor, MI). No differ-
ences in cholesterol levels were found between
ApoE–/– and DKO mice or in the different
treatment groups.
Lung histopathology for inflammation
and ﬁbrosis. To determine whether the extent
of lung inflammation and fibrosis in lungs
correlated with the extent of atherogenesis,
lungs were inflated after collection of BALF
with a 1:1 mixture of OCT and PBS and ﬁxed
in 4% paraformaldehyde. We stained parafﬁn
sections of lung (5 μm thickness) with hema-
toxylin and eosin (H&E) to quantify inﬂam-
mation or Masson’s trichrome technique for
detection of collagen (Sabo-Attwood et al.
2005). A board-certiﬁed pathologist (K.J.B.)
evaluated sections using a blind coding system,
as previously described (Craighead 1982;
Haegens et al. 2007). 
We scored inﬂammation on a scale from 1
to 4: 1, no inﬂammation; 2, mild inﬂammation
that was rarely peribronchiolar and consisted
primarily of lymphocytes; 3, moderate inﬂam-
mation with peribronchiolar neutrophils,
eosinophils, lymphocytes, and abundant
macrophages; and 4, severe inﬂammation with
peribronchiolar neutrophils, eosinophils, and
lymphocytes that extend to involve adjacent
alveolar septa and abundant bronchiolar and
intraalveolar macrophages. We also scored ﬁbro-
sis on a scale from 1 to 4: 1, no ﬁbrosis; 2, focal
ﬁbrosis; 3, moderate ﬁbrosis; 4, severe ﬁbrosis.
BALF differential cell counts. We enu-
merated total cells in BALF and centrifuged
2 × 104 cells onto glass slides at 600 rpm. We
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(Biochemical Sciences, Swedesboro, NJ), and
performed differential cell counts on
500 cells/mouse (Haegens et al. 2007).
Cytokine concentrations in BALF and
plasma. To determine whether altered
cytokine proﬁles occurred in the lung and the
systemic circulation, we initially measured
cytokines using an enzyme-linked immuno-
sorbent assay (ELISA). We used commercial
kits for interleukin-6 (IL-6), MCP-1, macro-
phage inflammatory protein-2 (MIP-2), and
interferon-γ (IFN-γ) (Endogen, Woburn, MA)
according to the manufacturer’s directions.
Brieﬂy, we aliquoted 2-fold dilutions of plasma
or BALF into 96-well microplates coated with
antibody to the indicated cytokines for 2 hr at
25°C. Plates were then washed, incubated with
biotin-conjugated secondary antibody, washed,
incubated with streptavidin–horseradish
peroxidase conjugate, washed again, and incu-
bated with 3,3´,5,5´-tetramethylbenzidine sub-
strate. The reaction was halted by adding the
stop solution in the plate reader at 450 nm and
analyzed using a Biotech EL808 ELISA Reader
(BioTek, Inc., Winooski, VT). We determined
cytokine concentrations from a standard curve
using reference standards supplied in the kit.
In subsequent studies, we also measured
cytokine and chemokine levels in BALF
using the Bio-Plex Protein Array System and
a mouse cytokine 22-plex panel (Bio-Rad,
Hercules, CA), as previously described (Sabo-
Attwood et al. 2005). This method of analy-
sis is based on Luminex technology and
simultaneously measures IL-1α, IL-1β, IL-2,
IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40),
IL-12 (p70), IL-13, IL-17, tumor necrosis
factor-α (TNF-α), regulated in activation,
normal T expressed and secreted (RANTES;
CCL5), MIP-1α, MIP-1β, MCP-1, CXCR2
ligand KC/GRO-α (KC), granulocyte-
colony–stimulating factor (G-CSF), granulo-
cyte/monocyte-colony–stimulating factor
(GM-CSF), IFN-γ, and eotaxin protein. We
determined concentrations of each cytokine
and chemokine using Bio-Plex Manager soft-
ware, Version 3.0 (Bio-Rad).
Electrophoretic mobility shift assay
(EMSA) and Western blot analyses for AP-1
and NF-κB in aortas. We used the EMSA to
determine whether inhaled particulates affected
the DNA binding of oxidant-associated tran-
scription factors in aortic tissue. Isolated aorta
was minced using sterile scissors and then
homogenized in a prechilled homogenizer.
Nuclear proteins were extracted as previously
described (Janssen et al. 1997; Schreiber et al.
1989). Brieﬂy, after homogenization, the cells
were lysed in hypotonic buffer and 0.6%
Nonidet P-40 (Sigma, St. Louis, MO). After
centrifugation, the supernatant containing
cytoplasmic proteins was collected and stored
at –80°C for later analysis. Nuclear proteins
were then extracted from the pelleted nuclei
(Janssen et al. 1997; Schreiber et al. 1989). 
Protein concentrations were measured
using the Bio-rad Protein Assay (Bio-Rad).
The AP-1 and NF-κB probes containing the
consensus sequences of AP-1 and NF-κB
binding sites, respectively, were synthesized
commercially (Promega, Madison, WI). The
oligos were then labeled with γ-32P-ATP
(NEN Life Science, Boston, MA) by T4
polynucleotide kinase (GIBCO-BRL,
Gaithersburg, MD). We incubated 20 μL of
each binding mixture, composed of 7 μg
nuclear protein in binding buffer with
40 mM HEPES (pH 7.8), 4% Ficoll 400,
200 μg/mL poly(dI:dC) [poly(deoxy-
inosinic:deoxycytidylic acid); Amersham
Pharmacia, Piscataway, NJ], 1 mM MgCl2,
0.1 mM dithiothreitol, and 1 μL of labeled
probe (0.02 pmol), at room temperature for
15 min and then loaded it onto a 5% sodium
dodecyl sulfate (SDS) polyacrylamide gel
(nondenaturing), as previously described
(Janssen et al. 1997; Mossman et al. 2000).
The gel was run in 0.25× Tris/borate/EDTA
buffer at 120 V for 2.5 hr, then dried and
exposed to X-ray film overnight at –80°C.
The autoradiographic films were scanned by
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Table 1. Immune cell inﬁltration in lung tissue after asbestos exposure.a
Exposure ApoE–/– DKO 
time (days) Control Asbestos Control Asbestos
3 1.0 ± 0 2.0 ± 0* 1.0 ± 0 2.1 ± 0.2*
9 1.0 ± 0 2.8 ± 0.3* 1.0 ± 0 2.5 ± 0.5*
30 1.0 ± 0 3.5 ± 0.2* 1.0 ± 0 3.2 ± 0.2*
aEvaluated on H&E-stained sections using a scoring system where 1 indicates no inﬁltration; 2, mild inﬁltration; 3, moder-
ate inﬁltration; and 4, severe inﬁltration. *p < 0.001 compared with control.
Table 2. Fibrosis in lung tissue after asbestos exposure.a
ApoE–/– DKO 
Exposure Asbestos Asbestos
time (days) Control Peribronchiolar Perivascular Control Peribronchiolar Perivascular
3 1.0 ± 0 1.0 ± 0 1.0 ± 0  1.0 ± 0 1.0 ± 0 1.0 ± 0
9 1.0 ± 0 1.5 ± 0.3 1.0 ± 0 1.0 ± 0 1.5 ± 0.5 1.5 ± 0.5
30 1.0 ± 0 1.8 ± 0.2* 1.3 ± 0.2 1.0 ± 0 2.3 ± 0.3* 1.0 ± 0
aEvaluated on lung sections stained with the Masson’s trichrome method to detect collagen, using a scoring system where
1 indicates no ﬁbrosis; 2, focal ﬁbrosis; 3, moderate ﬁbrosis; and 4, severe ﬁbrosis. *p < 0.001 compared with control.
Figure 2. Representative lung sections stained with Masson’s trichrome after 30-day exposures, showing
inﬂammatory cell inﬁltration and ﬁbrosis in asbestos-exposed animals. Blue indicates collagen associated
with fibrosis. (A) ApoE–/– mice exposed to clean air. (B) ApoE–/– mice exposed to TiO2. (C) DKO mice
exposed to clean air. (D) ApoE–/– mice exposed to asbestos. (E) DKO mice exposed to asbestos.
ApoE –/– clean air ApoE –/– TiO2 DKO clean air
ApoE –/– asbestos DKO asbestos
A B C
D E
Figure 1. Size (mean ± SE) of atherosclerotic
lesions after 30-day exposures of ApoE–/– mice to
clean air (n = 11), asbestos (n = 11), or TiO2 (n = 6),
and of DKO mice to clean air (n = 8) or asbestos
(n = 8). Error bars represent the variance in the
average lesion area per animal. 
*p < 0.001.
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TiO2densitometry and analyzed with Quantity
One Software, Version 4.2 (Bio-Rad).
We used cytoplasmic protein extracted
from the aortas during the preparation of
nuclear extracts for Western blot analysis to
conﬁrm the DNA binding of NF-κB by using
an antibody to phosphorylated Kappa B
inhibitor (IκB; Cell Signaling Technology,
Inc., Danvers, MA). Briefly, 20 μg protein
from each sample was electrophoresed on a
10% SDS-PAGE and electroblotted onto a
nitrocellulose membrane, which was then
incubated with the antibody overnight with
shaking at 4°C. After incubation, the protein
bands were visualized using a SuperSignal
West Pico Trial Kit (Pierce, Rockford, IL) and
exposed to radiographic ﬁlm. The blots were
reprobed with a β-actin antibody (Abcam,
Cambridge, MA) to detect cytoplasmic
β-actin as the loading control. The images and
densities were captured with a GS-700
Imaging Densitometer (Bio-Rad), analyzed
with Quantity One Software, and presented as
the ratio of IκB to β-actin.
Statistics. We used Student’s two-sample
t-tests to compare groups when the data were
normally distributed. We used the Mann-
Whitney test to compare groups using trans-
formed data to stabilize the variance or when
results were not normally distributed. Two-
way analysis of variance (ANOVA) was used
to analyze transformed cytokine/chemokine
data for each time point, with post hoc analy-
sis to determine genotype effects within treat-
ment or treatment effects within genotype.
We used chi-square analysis to compare the
histologic scores for ﬁbrosis and inﬂammation.
Nonparametric Kendall tau correlation coefﬁ-
cients were derived for the relationships
between lesion size and MCP-1 concentrations
in ApoE–/– mice. All analyses were performed
using SPSS, version 14, and data are presented
as mean ± SE.
Results
Aortic responses. We examined the effect of
inhaled chrysotile asbestos ﬁbers on the devel-
opment of atherosclerotic lesions in three sep-
arate but identical inhalation experiments
(n = 6–10 mice per group per time point per
experiment). We observed no detectable dif-
ferences in lesion size after 3- or 9-day expo-
sures to asbestos. However, as determined by
lipid staining with oil red O, lesions in the
region of the aortic sinus to the aortic valve in
30-day asbestos-exposed ApoE–/– mice, were
approximately three times larger (p < 0.001 by
ANOVA) than lesions in control, TiO2-
exposed ApoE–/– mice or in asbestos-exposed
DKO animals (Figure 1). Fiber analyses
showed only one or two small fibers in two
ﬁelds of an aorta preparation from a clean-air
control animal, which we concluded was likely
caused by contamination from the previous
processing of a lung sample. The rest of the
aorta samples were free of fibers. These data
suggest that asbestos-induced aortic effects
are not due to direct translocation of ﬁbers to
aortic tissue.
Lung responses. To determine whether the
degree of lung inflammation and fibrosis in
response to particulates correlated with the
amount of atherosclerosis observed in the dif-
ferent groups of mice, we examined lung sec-
tions and graded them using an established
blind coding system developed for asbestosis
in human lung (Craighead 1982; Haegens
et al. 2007). Figure 2 shows representative
lung sections from a clean-air–exposed
ApoE–/– mouse (Figure 2A), a TiO2-exposed
ApoE–/– mouse (Figure 2B), and a clean-air–
exposed DKO mouse (Figure 2C) after
30 days and demonstrates the absence of
inﬂammation and ﬁbrosis. In contrast, histo-
logic analysis of lungs from both the ApoE–/–
(Figure 2D) and DKO (Figure 2E) mice
showed striking peribronchiolar inﬂammation
and fibrosis originating at distal bronchioles
and alveolar duct regions after 30 days of
asbestos exposure. As shown in Table 1
(which summarizes the grading of inﬂamma-
tory cell infiltration) and Table 2 (which
summarizes peribronchiolar/perivascular
ﬁbrosis) in H&E-stained lung sections, both
ApoE–/– and DKO mice had significantly
greater immune cell inﬁltration after 3, 9, and
30 days of exposure to asbestos compared
with exposure to clean air (p < 0.001).
Fibrosis was not elevated until 30 days, and
peribronchiolar fibrosis was significantly
greater in asbestos-exposed ApoE–/– and
DKO mice compared with the respective
clean-air controls (p < 0.001). We detected no
differences in the fibrotic or inflammatory
scores for lungs between asbestos-exposed
ApoE–/– and DKO mice at any time point.
Figure 3 shows differential cell counts in
BALF and also demonstrates similar changes
Asbestos and atherosclerosis in ApoE–/– mice
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Figure 3. Differential cell counts (mean ± SE) in BALF from ApoE–/– and DKO mice after exposure for 3 days
(A), 9 days (B), or 30 days (C) to clean air or asbestos. Error bars represent the variance of the averages of
the respective cell counts per animal. Eos, eosinophils; Lymph, lymphocytes; Mac, macrophages; Neutro,
neutrophils.
*p < 0.05, **p < 0.01, and #p < 0.001, compared with respective clean-air–exposed animals (n = 5–10 animals per group per
treatment).
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*in the inﬂammatory responses of ApoE–/– and
DKO mice after 3, 9, and 30 days of asbestos
exposure compared with respective clean-air
control animals. Total cell numbers and num-
bers of macrophages were higher in 9-day
clean-air–exposed DKO mice, but the overall
response to asbestos was similar to that in the
9-day ApoE–/– mice. Asbestos exposure
significantly increased total neutrophils and
eosinophils in both ApoE–/– and DKO mice
at all time points.
Cytokine and chemokine concentrations
in BALF and plasma by ELISA. In initial
experiments to determine whether cytokine
and chemokine profiles in BALF or plasma
correlated with atherogenic responses, we
measured concentrations of four inflamma-
tory cytokines (IL-6, IFN-γ, MCP-1, and
MIP-2) previously associated with lung
inflammation after asbestos exposure
(Haegens et al. 2007; Sabo-Attwood et al.
2005), as well as the appearance of athero-
sclerosis (Hansson 2001) in BALF and in
plasma obtained from ApoE–/– mice exposed
to clean air or chrysotile asbestos fibers for
30 days. In BALF, levels of MCP-1, IL-6, and
MIP-2, a potent chemotactic factor for
monocyte and neutrophil recruitment, were
signiﬁcantly increased (p < 0.04) in asbestos-
exposed ApoE–/– animals, whereas levels of
IFN-γ were comparable in clean-air–exposed
and asbestos-exposed groups (Figure 4A). We
were also interested in whether plasma levels
of these cytokines were elevated at 30 days,
suggesting either systemic signaling to aortic
tissue or their production by circulating
inflammatory cells. In contrast to the other
cytokines measured, only MCP-1 concentra-
tions in plasma were significantly higher
(p < 0.04) in asbestos-exposed compared with
clean-air–exposed ApoE–/– mice at 30 days
(Figure 4B). Furthermore, plasma levels of
MCP-1 significantly correlated with athero-
sclerotic lesion sizes in asbestos-exposed
ApoE–/– mice (p < 0.04).
Cytokine and chemokine levels in BALF
and plasma using the Bio-Plex assay. In later,
more comprehensive experiments, we used
the Bio-Plex assay for analysis of cytokines/
chemokines in BALF of asbestos-exposed
ApoE–/– and DKO mice after 3, 9, and
30 days of exposure. At 3 days, both ApoE–/–
and DKO mice exposed to asbestos showed
increased levels of MCP-1 (p < 0.01), G-CSF
(p < 0.001), IL-5 (p < 0.01), IL-4 (p < 0.05),
KC (p < 0.05), and IL-6 (p < 0.001) in BALF
(Figure 5A). TNF-α in BALF was increased
signiﬁcantly only in ApoE–/– mice exposed to
asbestos (p < 0.05); levels were significantly
higher in ApoE–/– mice than in DKO mice
(p < 0.02). The magnitudes of MCP-1 and
IL-6 concentrations in BALF were similar in
both ApoE–/– and DKO mice after 3 days of
asbestos exposure. However, none of the
other cytokines on the panel were signifi-
cantly altered at this time point.
After 9 days of asbestos exposure, which
has previously been shown to be the time point
of the maximum inflammatory response in
lung after inhalation of chrysotile asbestos
fibers (Haegens et al. 2007; Sabo-Attwood
et al. 2005), MCP-1 in BALF remained ele-
vated, with ApoE–/– mice having an approxi-
mately 2-fold greater response than the DKO
mice (p < 0.03) (Figure 5B). We observed
increased BALF levels of G-CSF (p < 0.01),
IL-5 (p < 0.05), IL-4 (p < 0.05), KC (p < 0.05),
and IL-6 (p < 0.01) in both ApoE–/– and DKO
mice exposed to asbestos. Interestingly, the
DKO mice had relatively lower TNF-α levels
in BALF compared with the ApoE–/– animals
after either 3 or 9 days of exposure.
As shown in Figure 5C, signiﬁcant eleva-
tions in BALF cytokines in both asbestos-
exposed ApoE–/– and DKO animals were
sustained at 30 days for MCP-1 (p < 0.001),
IL-4 (p < 0.05), and KC (p < 0.01). In contrast,
only G-CSF (p < 0.05) and IL-6 (p < 0.01)
levels remained significantly elevated in
asbestos-exposed ApoE–/– mice compared with
clean-air–exposed animals. After asbestos expo-
sure for 30 days, differences between ApoE–/–
and DKO animals were found in BALF for
MCP-1 (p < 0.03; mean ± SE, 491 ±
417 pg/mL in ApoE–/– mice vs. 176 ± 107
pg/mL for DKO mice) and IL-6 (p < 0.03;
Fukagawa et al.
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Figure 4. Cytokine concentrations (mean ± SE) in BALF (A) and plasma (B) obtained from ApoE–/– mice
exposed to clean air or asbestos for 30 days (n =11 per group). Error bars represent the variance of the
averages of values obtained in each animal. 
*p < 0.04 compared with respective clean-air–exposed animals.
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Figure 5. Cytokine and chemokine concentrations (mean ± SE) in BALF from ApoE–/– and DKO mice exposed
to clean air or chrysotile asbestos for 3 days (A), 9 days (B), or 30 days (C), as analyzed by the Bio-Plex
assay. Error bars represent the variance of the averages of respective values from each animal. 
*p < 0.05, **p < 0.01, and #p < 0.001, compared with respective clean-air–exposed animals.
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)45 ± 46 pg/mL in ApoE–/– vs. 7.4 ± 7.6 pg/mL
in DKO mice) (Figure 5C).
Using the Bio-Plex assay on a subset of
available ApoE–/– and DKO plasma samples
obtained in one 30-day exposure experiment,
we found an approximately 49% increase in
MCP-1 levels in the ApoE–/– animals (clean
air, 86 ± 30 pg/mL, n = 4; asbestos, 128 ± 51,
n = 5). The magnitude of the change was sim-
ilar to that found when using the ELISA
assay. In contrast, we found no difference in
MCP-1 concentrations between the clean-
air–exposed and asbestos-exposed DKO mice
(180 ± 9 pg/mL, n = 3, vs. 177 ± 70 pg/mL,
n = 6, respectively). The levels in DKO mice
were higher than those measured in ApoE–/–
mice using both assays, but asbestos exposure
did not elicit a change in the concentrations in
plasma as it did in the ApoE–/– mice. The Bio-
Plex data followed patterns similar to those
shown in Figure 4B for the ApoE–/– mice. We
found no differences in the clean-air–exposed
versus asbestos-exposed DKO mice for IL-6
(0.7 ± 0.4 vs. 0.7 ± 1.5 pg/mL, respectively),
TNF-α (29 ± 32 vs. 42 ± 54 pg/mL), or
IFN-γ (0.2 ± 0.2 vs. 0.4 ± 0.6 pg/mL).
AP-1 and NF-κB activation in the aorta.
Binding sites for both AP-1 and NF-κB (oxi-
dant-induced transcription factors associated
with inﬂammation) are found in the promoter
region of the MCP-1 gene, and their coopera-
tive action is important in the induction of
MCP-1 gene expression (Martin et al. 1997).
Although it is well known that both AP-1 and
NF-κB are activated in the lung after asbestos
exposure (Haegens et al. 2007; Janssen et al.
1997; Mossman et al. 2000) and that MCP-1
is important in the initiation of atherosclerosis
(Gosling et al. 1999), distal changes in AP-1
and NF-κB binding to DNA in the aorta after
inhalation of asbestos are novel ﬁndings. Data
in Figure 6A and B demonstrate significant
activation of both AP-1 and NF-κB, respec-
tively, in the aorta from ApoE–/– mice after
9 days of asbestos exposure, consistent both
with patterns of early and signiﬁcant inﬂam-
matory responses in lung tissue (Table 1) and
with rises in MCP-1 levels in BALF (Figure 4).
Figure 6C and D shows no AP-1 or NF-κB
DNA binding, respectively, in aortas isolated
from DKO mice exposed to clean air or
asbestos. Western blot analyses for phosphory-
lated IκB in cytoplasmic protein extracted
from the aortas also revealed increased levels
relative to levels of β-actin, a loading control
protein, after 9 days of asbestos exposure in
ApoE–/– mice (Figure 7A) but not in DKO
mice (Figure 7B). Phosphorylated IκB releases
the NF-κB complex for translocation to the
nucleus; therefore, the increase in phosphory-
lated IκB found in the 9-day samples is consis-
tent with the increased DNA binding activity
of NF-κB in ApoE–/– mice at this point as
shown by EMSA (Figure 6).
Discussion
These data are the first to show that inhaled
chrysotile asbestos, a documented pathogenic
airborne fiber, exacerbates atherosclerotic
lesions in chow-fed ApoE–/– mice. It should be
noted that concentrations of airborne asbestos
fibers generated in this study were high, as
encountered episodically during the World
Trade Center disaster, in contrast to mean
ambient levels in buildings (0.00004 and
0.00243 ﬁbers/mL air in rural and urban sam-
ples, respectively) or outdoor air (0.00001 and
0.0001 ﬁbers/mL air in rural and urban sam-
ples, respectively) (Health Effects Institute
1991). Atherosclerotic effects were attenuated
significantly when animals also lack CD4+
Asbestos and atherosclerosis in ApoE–/– mice
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Figure 6. Results of EMSA for NF-κB and AP-1 in aortic extracts. (A,B) DNA binding of AP-1 (A) and NF-κB
(B) in aortic extracts from ApoE–/– mice exposed to clean air (control; lanes 1–4) or to chrysotile asbestos
for 3 days (lanes 5–8), 9 days (lanes 9–12 ), or 30 days (lanes 13–16). Data are expressed relative to OCT-1
compound as a loading control. Values in top portions of A and B are mean ± SE; error bars represent the
variance of the averages of values obtained for each animal. (C,D) DNA binding of AP-1 (C) and NF-κB( D)
in aortic extracts from DKO mice exposed to clean air (lanes 1–4) or to asbestos for 3 days (lanes 5–7), 9
days (lanes 8–11), or 30 days (lanes 12–14). Lane 15 represents a positive control. Arrows denote bands for
respective transcription factor binding.
**p < 0.01 compared with control (n = 4 per group).
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Figure 7. Results of Western blot analyses for phosphorylated IκB (p-IκB). (A) Western blot analyses
(mean ± SE; n = 4 per group) for p-IκB/β-actin ratios in cytoplasmic extracts from aortas of ApoE–/– mice
exposed to clean air (control) or chrysotile asbestos for 3, 9, or 30 days (left), and an example of a Western
blot comparing clean air with 9-day exposures (right). (B) Western blot analyses (mean ± SE; n = 4 per
group) for p-IκB/β-actin ratios in cytoplasmic extracts from aortas of DKO mice exposed to clean air (con-
trol) or chrysotile asbestos for 3, 9, or 30 days (left), and an example of the Western blot comparing clean
air with 9-day exposures (right). Blots are not shown for 3- and 30-day exposures because there were no
signiﬁcant changes.
*p < 0.02 compared with clean air exposure.
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β-ActinT cells, showing their critical importance in the
pathogenesis of disease. The fact that DNA
binding of both AP-1 and NF-κB were
increased in nuclear extracts from aortas of
ApoE–/– mice after 9 days of asbestos exposure,
in the absence of asbestos ﬁbers in the aortas,
indicates that distal signaling mechanisms
involving these two transcription factors are
activated in atherogenesis. We found no
detectable differences in AP-1 and NF-κB
DNA binding activity in extracts from aortas
of DKO mice exposed to either clean air or
asbestos, which provides additional support for
the important interactions among asbestos
exposure, CD4+ T cells, and lesion develop-
ment through redox-sensitive signaling path-
ways. Furthermore, our studies suggest that
MCP-1, which has binding sites for both AP-1
and NF-κB in its promoter region, is an
important chemokine in the signaling events
leading to atherosclerosis. Recently, Sun et al.
(2005) reported that ApoE–/– mice fed a high-
fat diet and exposed to inhaled particulate mat-
ter had increased atherosclerotic lesions that
were accompanied by increased macrophage
inﬁltration and evidence of oxidative stress in
the aorta. However, they did not identify the
link between lung effects and these ﬁndings in
aortic tissue and mechanisms of particulate
matter–induced atherosclerosis.
Atherosclerosis is a complex disease with
etiologies that involve both genetic and envi-
ronmental factors. The present study conﬁrms
the importance of inﬂammation in the athero-
genic process and supports a role for the CD4+
T cell, shown to be present in atherosclerotic
lesions (Zhou et al. 1996). Although we did
not stain for the presence of CD4+ T cells in
lesions in these experiments, we did ﬁnd more
circulating CD4+ T cells in the blood of a
small subset of ApoE–/– mice exposed to
asbestos compared with a subset exposed to
clean air for 30 days, although the differences
were not significant (data not shown). Early
work using ApoE–/– mice crossed with IFN-γ
receptor–deﬁcient mice suggested that IFN-γ
promoted atherosclerosis and was critical in
modulating the balance between TH1 (cellular
immunity) and TH2 (humoral immunity) sub-
sets of T cells (Gupta et al. 1997). Exogenous
IFN-γ has also been shown to increase athero-
sclerosis in ApoE–/– mice (Whitman et al.
2000). IL-4 is reportedly necessary for invok-
ing a TH2 response (Feili-Hariri et al. 2005)
and has been shown to play a role in the pro-
gression of atherosclerosis (Davenport and
Tipping 2003). IL-4 levels were increased simi-
larly in BALF of both ApoE–/– and DKO mice
exposed to asbestos for 3, 9, or 30 days, but
levels were not detectable in plasma.
Elhage et al. (2004) reported that DKO
mice had increased lesions in the descending
and abdominal aorta, but they found similar
lesions in the aortic sinuses of ApoE–/– mice.
We recognize that the lesions observed in the
present study are larger than reported in the
literature for ApoE–/– mice of similar age. The
reasons for the differences between the present
work and previous reports are unclear but may
relate to the study design and housing condi-
tions. We chose to start the exposures to
asbestos at 4–6 weeks of age and to terminate
the experiments after 30 days of exposure
(5 days/week, for a total of 6 weeks) when ani-
mals were at most 12 weeks of age. Because we
examined only the aortic sinus, extending the
exposures to 18 weeks or 1 year or doing en
face analysis may have yielded different results.
However, our objective was to determine
whether the length of exposure to asbestos nec-
essary to develop lung inﬂammation and early
fibrosis was sufficient to elicit differences in
aortic responses between ApoE–/– and DKO
mice. Of major signiﬁcance here is that both
ApoE–/– and DKO mice appeared to respond
similarly to asbestos exposure with respect to
lung inflammation, fibrosis, and selected
cytokine concentrations in BALF but differed
signiﬁcantly in their responses in plasma con-
centrations of MCP-1 after 30 days of expo-
sure to asbestos. ApoE–/– mice exposed to
asbestos had an increase in plasma MCP-1 lev-
els compared with clean-air–exposed animals.
In contrast, MCP-1 concentrations in DKO
mice, although constitutively higher, remained
unchanged after clean air and asbestos expo-
sure. In BALF, genotype differences in
response became apparent at 9 and 30 days of
exposure to asbestos in that MCP-1 and IL-6
were higher in ApoE–/– than in DKO mice.
The source of these cytokines remains
unknown, and future studies will examine
changes induced by asbestos in MCP-1–deﬁ-
cient mice crossed with ApoE–/– mice.
Our data showing elevated levels of plasma
MCP-1 in asbestos-exposed ApoE–/– mice are
consistent with growing evidence that
cytokines participate as autocrine and paracrine
mediators in the pathogenesis of atherosclerosis
(Hansson 2001; Upadhya et al. 2004). Because
elevated levels of MCP-1 are known to occur
in BALF after inhalation of chrysotile asbestos
in C57BL/6 mice (Haegens et al. 2007), neu-
trophils elaborating MCP-1 may enter the sys-
temic circulation. Alternatively, cells activated
in the lung by asbestos [e.g., macrophages,
dendritic cells (DCs), neutrophils, lympho-
cytes] may migrate to pulmonary lymph nodes,
where they activate CD4+ T cells that are
released into the circulation and contribute to
atherogenesis. This latter explanation could
account for the remarkably similar inﬂamma-
tory and fibrotic patterns in the lungs of
ApoE–/– and DKO mice, but the dramatically
different extent of atherosclerotic lesions in
their aortas. The elevation of systemic levels of
MCP-1 and the significant relationship
between plasma MCP-1 concentrations and
lesion size in the ApoE–/– mice provide support
for previous work showing the importance of
MCP-1 in atherogenesis (Gosling et al. 1999;
Hansson 2001). DKO mice had higher plasma
MCP-1 levels than did ApoE–/– mice, but
asbestos had no effect compared with clean air
in these mice. This suggests that constitutive
levels may be higher in DKO mice but that
higher levels are not necessarily associated with
larger lesions. It appears that the induced
change in concentrations is of greater impor-
tance in the pathogenesis of the disease, high-
lighting the complex interrelationships.
Our work also demonstrates that many
classically defined inflammatory cytokines/
chemokines (e.g., KC, MIP-1α, MIP-1β,
IL-6) are elevated in BALF in this model, but
these differences appear to be dissociated from
effects seen in the aorta. Previous studies have
revealed that MCP-1 is necessary for the acti-
vation of T lymphocytes (Taub et al. 1995)
and that MCP-1 produced by lung ﬁbroblasts
exerts an immunomodulatory effect on CD4+
T cells in vitro (Hogaboam et al. 1998).
G-CSF and KC, both important in neutrophil
recruitment, were elevated in our studies, but
not GM-CSF, which is an important growth
factor for lung DC maturation and prolifera-
tion (Vermaelen and Pauwels 2005). However,
because DCs are central to the initiation and
orchestration of immunity and tolerance, we
suggest that asbestos ﬁbers initiate an inﬂam-
matory cascade in lung epithelial cells and
macrophages, cells ﬁrst encountering inhaled
asbestos, thus leading to secretion of cytokines
and chemokines with DC-attracting potential.
DCs then could migrate to lymph nodes,
where they activate T cells, which enter the sys-
temic circulation and come into contact with a
vulnerable aorta, an observation consistent
with the detection of macrophages and CD4+
T cells in early aortic lesions (Zhou et al.
1996). Further inﬂammatory cell inﬁltration
would then exacerbate lesion development.
Investigation is ongoing to document a role for
DCs in the translation of asbestos-induced pul-
monary inﬂammation to systemic responses.
In summary, exposure to inhaled chrysotile
asbestos ﬁbers was associated with an exacerba-
tion of the development of atherosclerotic
lesions in ApoE–/– mice. The induction of
atherosclerosis appears to be CD4+ T cell
dependent and dissociated from the magni-
tude of lung inﬂammation or ﬁbrosis associ-
ated with inhaled asbestos. More important,
our data also suggest the importance of a
change in systemic MCP-1 in atherogenesis
associated with altered signaling through the
transcription factors AP-1 and NF-κB, and
that the effects of inhaled asbestos extend
beyond the lung. The data also raise the pos-
sibility of constitutive differences in MCP-1
levels between the different genotypes that
warrant further investigation.
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